Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 21.19m |
Free float | 19.90m |
P/E (TTM) | -- |
Market cap | 244.73m USD |
EPS (TTM) | -5.46 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
- Enanta Pharmaceuticals to Participate in Investor Conferences in September
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET